Published in Biochem J on November 01, 1972
Effect of phenylpyruvate on enzymes involved in fatty acid synthesis in rat brain. Biochem J (1973) 1.05
Phenylalanine metabolism in isolated rat liver cells. Effects of glucagon and diabetes. Biochem J (1981) 0.97
Phenethylamines in brain and liver of rats with experimentally induced phenylketonuria-like characteristics. Biochem J (1973) 0.86
The enduring behavioral changes in rats with experimental phenylketonuria. Proc Natl Acad Sci U S A (1974) 0.80
Neuropathological findings in phenyl-pyruvic oligophrenia (phenyl-ketonuria). J Neuropathol Exp Neurol (1950) 2.48
AN AUTOMATED PROCEDURE FOR BLOOD PHENYLALANINE. Clin Chem (1965) 2.47
A chemical investigation of the defects of myelination in phenylketonuria. J Neurol Neurosurg Psychiatry (1962) 2.39
Phenylketonuria: mental development, behavior, and termination of low phenylalanine diet. J Pediatr (1968) 2.33
Filter paper blood collection and punching as a means of quantification. Clin Chem (1969) 1.49
Blood-brain barrier for adrenaline. Science (1959) 1.42
On the identity of DOPA decarboxylase and 5-hydroxytryptophan decarboxylase (immunological titration-aromatic L-amino acid decarboxylase-serotonin-dopamine-norepinephrine). Proc Natl Acad Sci U S A (1972) 1.21
Isolation and properties of aromatic alpha-keto acid reductase. J Biol Chem (1966) 1.10
Inhibition of human brain pyruvate kinase and hexokinase by phenylalanine and phenylpyruvate: possible relevance to phenylketonuric brain damage. Proc Natl Acad Sci U S A (1969) 1.05
Inhibition of sterol synthesis in vitro by metabolites of phenylalanine. Biochim Biophys Acta (1969) 1.03
Inhibition of DOPA decarboxylase by aromatic acids associated with phenylpyruvic oligophrenia. Proc Soc Exp Biol Med (1956) 0.97
Enduring behavioral changes in rats with experimental phenylketonuria. Proc Natl Acad Sci U S A (1972) 0.94
Possible biochemical model for phenylketonuria. Nature (1972) 0.92
Occurrence and distribution of L-DOPA decarboxylase in the human brain. Brain Res (1970) 0.90
Differences in the regulation of tyrosine aminotransferase in brain and liver. J Neurochem (1970) 0.89
Biochemical studies on phenylketonuria I. Experimental hyperphenylalanemia in the rat. J Biol Chem (1961) 0.85
Phenylketonuria metabolites in cerebellum culture morphology. Arch Neurol (1967) 0.82
Aromatic acid excretion in phenylketonuria. Analysis of the unconjugated aromatic acids derived from phenylalanine. Clin Chim Acta (1970) 0.82
Automated fluorometric determination of tyrosine in blood. Anal Biochem (1967) 0.79
Determination of p-halogenated phenylalanines and phenylalanine in plasma. Anal Biochem (1971) 0.78
Chest radiograph reading and recording system: evaluation for tuberculosis screening in patients with advanced HIV. Int J Tuberc Lung Dis (2010) 2.60
Comparison of cefoperazone, cefotaxime, and moxalactam (LY127935) against aerobic gram-negative bacilli. Antimicrob Agents Chemother (1980) 2.35
Cloning and characterization of a phosphopantetheinyl transferase from Streptomyces verticillus ATCC15003, the producer of the hybrid peptide-polyketide antitumor drug bleomycin. Chem Biol (2001) 2.25
Serum susceptibility of Haemophilus somnus from bovine clinical cases and carriers. J Clin Microbiol (1985) 1.51
Effect of food on hepatic blood flow: implications in the "food effect" phenomenon. Clin Pharmacol Ther (1983) 1.43
Mechanisms of enhanced oral availability of CYP3A4 substrates by grapefruit constituents. Decreased enterocyte CYP3A4 concentration and mechanism-based inactivation by furanocoumarins. Drug Metab Dispos (1997) 1.43
Killing of Brucella abortus by bovine serum. Infect Immun (1988) 1.41
Problems in regaining full extension of the knee after anterior cruciate ligament reconstruction: does arthrofibrosis exist? Knee Surg Sports Traumatol Arthrosc (1994) 1.41
Primary Cancer of the Lung. Cal West Med (1945) 1.38
Deprenyl is metabolized to methamphetamine and amphetamine in man. Br J Clin Pharmacol (1978) 1.35
Disposition of intravenous and oral cyclosporine after administration with grapefruit juice. Clin Pharmacol Ther (1995) 1.28
Vancomycin pharmacokinetics in a patient population: effect of age, gender, and body weight. Ther Drug Monit (1994) 1.24
Alpha1-acid glycoprotein concentration and protein binding in trauma. Clin Pharmacol Ther (1982) 1.23
Effects of a three-year exercise program on motor function and cognitive processing speed in older women. Res Q Exerc Sport (1991) 1.19
Comparison of chromatographic and spectrophotometric analysis of indocyanine green in plasma following administration of multiple doses to humans. J Pharm Sci (1982) 1.18
Trough concentrations of cyclosporine in blood following administration with grapefruit juice. Br J Clin Pharmacol (1993) 1.15
Increased theophylline concentrations secondary to ciprofloxacin. Drug Intell Clin Pharm (1987) 1.13
The analysis of hexitols in biological fluid by selected ion monitoring. Biomed Mass Spectrom (1980) 1.12
A model of insulin fibrils derived from the x-ray crystal structure of a monomeric insulin (despentapeptide insulin). Proteins (1997) 1.07
Some problems of alpha-fetoprotein screening. Lancet (1978) 1.06
Vancomycin protein binding in patients with infections caused by Staphylococcus aureus. DICP (1991) 1.03
Effect of norfloxacin on theophylline pharmacokinetics at steady state. Antimicrob Agents Chemother (1988) 1.02
Pharmacodynamics and pharmacokinetics of single doses of subcutaneous pegylated human G-CSF mutant (Ro 25-8315) in healthy volunteers: comparison with single and multiple daily doses of filgrastim. Am J Hematol (2001) 1.02
Tranylcypromine ('Parnate') overdose: measurement of tranylcypromine concentrations and MAO inhibitory activity and identification of amphetamines in plasma. Psychol Med (1979) 0.98
One brief exposure to a psychological stressor induces long-lasting, time-dependent sensitization of both the cataleptic and neurochemical responses to haloperidol. Life Sci (1992) 0.97
Colour stabilization of stained phospholipid spots in the determination of the amniotic fluid lecithin/sphingomyelin ratio. Clin Chim Acta (1975) 0.96
Contrasting effects of fluconazole and ketoconazole on phenytoin and testosterone disposition in man. Br J Clin Pharmacol (1992) 0.96
Clinical pharmacokinetics of oral cephalosporins. Antibiot Chemother (1971) (1995) 0.96
Interactions of phenol and m-cresol in the insulin hexamer, and their effect on the association properties of B28 pro --> Asp insulin analogues. Biochemistry (1998) 0.95
The biosynthetic gene cluster for the anticancer drug bleomycin from Streptomyces verticillus ATCC15003 as a model for hybrid peptide-polyketide natural product biosynthesis. J Ind Microbiol Biotechnol (2001) 0.93
Effect of mild and moderate liver disease on the pharmacokinetics of isavuconazole after intravenous and oral administration of a single dose of the prodrug BAL8557. Antimicrob Agents Chemother (2009) 0.92
Recent advances: the cytochrome P450 enzymes. Ann Pharmacother (1995) 0.92
Prior stress attenuates the analgesic response but sensitizes the corticosterone and cortical dopamine responses to stress 10 days later. Psychopharmacology (Berl) (1989) 0.90
Bioavailability of syrup and tablet formulations of cefetamet pivoxil. Antimicrob Agents Chemother (1993) 0.90
Itraconazole and hydroxyitraconazole serum concentrations are reduced more than tenfold by phenytoin. Clin Pharmacol Ther (1995) 0.90
Endometrial cancer metastasis presenting as a grossly swollen toe. Int J Gynecol Cancer (2003) 0.90
Factors affecting quinidine protein binding in humans. J Pharm Sci (1984) 0.89
In vitro interactions between beta-lactam antibiotics and tobramycin. Clin Chem (1981) 0.89
Adrenal epinephrine and norepinephrine release to hypoglycemia measured by microdialysis in conscious rats. Am J Physiol (1997) 0.88
Cefetamet pivoxil: a review of its microbiology, toxicology, pharmacokinetics and clinical efficacy. Int J Antimicrob Agents (1992) 0.88
Gas chromatography of volatile amino acid derivatives. IV. Mixed stationary phases for the separation of N-trifluoroacetylated amino acid n-amyl esters. J Chromatogr (1967) 0.87
Urinary phenylethylamine excretion: gas chromatographic assay with electron-capture detection of the pentafluorobenzoyl derivative. J Chromatogr (1979) 0.87
Transcranial direct current stimulation (tDCS) and robotic practice in chronic stroke: the dimension of timing. NeuroRehabilitation (2013) 0.87
Breakdown of trifluoroacetylated esters of cysteine and hydroxyl amino acids during gas chromatography: effects caused by some polar stationary phases. Biochim Biophys Acta (1966) 0.86
A radiological method for producing precise limb alignment. J Bone Joint Surg Br (1991) 0.86
Phenethylamines in brain and liver of rats with experimentally induced phenylketonuria-like characteristics. Biochem J (1973) 0.86
Triphosphopyridine nucleotide specific isocitrate dehydrogenase from Azotobacter vinelandii. Alkylation of a specific methionine residue and amino acid sequence of the peptide containing this residue. Biochemistry (1974) 0.84
Displacement of lidocaine from serum alpha 1-acid glycoprotein binding sites by basic drugs. Eur J Clin Pharmacol (1983) 0.84
Alanine aminopeptidase and beta 2-microglobulin excretion in patients receiving vancomycin and gentamicin. Antimicrob Agents Chemother (1987) 0.84
Predicted tissue accumulation of netilmicin in patients. Antimicrob Agents Chemother (1981) 0.84
The effect of coadministration of verapamil on the pharmacokinetics and metabolism of quinidine. Clin Pharmacol Ther (1987) 0.83
Clinical pharmacokinetics of pethidine: 1982. Clin Pharmacokinet (1983) 0.83
Pharmacokinetics of ceftriaxone in patients undergoing continuous veno-venous hemofiltration. J Clin Pharmacol (1996) 0.83
Effect of buprenorphine on CYP3A activity in rat and human liver microsomes. Life Sci (2000) 0.83
The pharmacokinetics of meperidine in acute trauma patients. J Trauma (1986) 0.83
Phenylalanine loading and aromatic acid excretion in normal subjects and heterozygotes for phenylketonuria. Clin Chim Acta (1973) 0.83
Pharmacokinetics of tranylcypromine in patients who are depressed: relationship to cardiovascular effects. Clin Pharmacol Ther (1986) 0.82
Some aspects of the epidemiology of equine salmonellosis. Aust Vet J (1988) 0.82
Aromatic acid excretion in phenylketonuria. Analysis of the unconjugated aromatic acids derived from phenylalanine. Clin Chim Acta (1970) 0.82
The effects of lithium on a potential cycling model of bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry (1998) 0.82
The effects of imipramine and iprindole on the metabolism of octopamine in the rat. Neuropharmacology (1985) 0.82
Phenylethylamine: evidence for a direct, postsynaptic dopamine-receptor stimulating action. Brain Res (1977) 0.81
Lack of effect of smoking on the metabolism and pharmacokinetics of quinidine in patients. Br J Clin Pharmacol (1987) 0.81
Effects of experience in a dynamic environment on postural control. Br J Sports Med (2007) 0.81
Crystal structure of a chimeric Fab' fragment of an antibody binding tumour cells. J Mol Biol (1992) 0.81
The effect of verapamil on antipyrine pharmacokinetics and metabolism in man. Br J Clin Pharmacol (1986) 0.80
Changes in plasma levels of calcium and in bone marrow mitosis after antigenic challenge in rats and mice. J Endocrinol (1981) 0.80
Simultaneous quantitation of disopyramide and its mono-dealkylated metabolite in human plasma by fused-silica capillary gas chromatography using nitrogen-phosphorus specific detection. J Chromatogr (1984) 0.80
Evaluation of dosage-release formulations on inhibition of drug clearance: effect of sustained- and immediate-release verapamil on propranolol pharmacokinetic parameters. Ther Drug Monit (1994) 0.80
Letter: Prenatal diagnosis of hypophosphatasia. Lancet (1976) 0.80
Applicability of capillary gas liquid chromatography to the measurement of free fraction of disopyramide in human plasma. Res Commun Chem Pathol Pharmacol (1985) 0.79
Adrenal medullary catecholamine secretion patterns in rats evoked by reflex and direct neural stimulation. Clin Exp Hypertens (2000) 0.79
Protein binding characteristics of bumetanide. Dev Pharmacol Ther (1989) 0.79
Serum requirement for growth and immunoglobulin synthesis by cultured human lymphocyte lines. Dev Biol Stand (1979) 0.79
Plasma tranylcypromine: relationship to pharmacokinetic variables and clinical antidepressant actions. J Clin Psychopharmacol (1990) 0.78
Long-term oscillation of corticosterone following intermittent cocaine. J Neural Transm (Vienna) (2000) 0.78
Effects of L-DOPA on the excretion of alcoholic metabolites of catecholamines and trace amines in rat and human urine. Biochem Med (1981) 0.78
Determination of urinary methylhistamine excretion in male and female rats by gas chromatography with electron-capture detection. Life Sci (1980) 0.78
Analysis of phenylethylamines in biological tissues by gas-liquid chromatography with electron-capture detection. Anal Biochem (1972) 0.78
Exocrine-gland function and the basic biochemical defect in cystic fibrosis. Lancet (1978) 0.78
One experience with 'lower' or 'higher' intensity stressors, respectively enhances or diminishes responsiveness to haloperidol weeks later: implications for understanding drug variability. Brain Res (1991) 0.78
Neurochemical and physiological effects of cocaine oscillate with sequential drug treatment: possibly a major factor in drug variability. Neuropsychopharmacology (1995) 0.78
Behavioral effects of a single neuroleptic treatment grow with the passage of time. Brain Res (1986) 0.78
Studies of information processing in sleep. Psychophysiology (1975) 0.78
Stressor-induced oscillation. A possible model of the bidirectional symptoms in PTSD. Ann N Y Acad Sci (1997) 0.78
Effects of L-dopa on dopamine and norepinephrine concentrations in rat brain assessed by gas chromatography. J Chromatogr (1981) 0.78
Oscillatory-sensitization model of repeated drug exposure: cocaine's effects on shock-induced hypoalgesia. Prog Neuropsychopharmacol Biol Psychiatry (1998) 0.78
Selective radiochemical labeling of types A and B active sites of rat liver monoamine oxidase. Biochem Biophys Res Commun (1979) 0.77
Amphetamine or haloperidol 2 weeks earlier antagonized the plasma corticosterone response to amphetamine; evidence for the stressful/foreign nature of drugs. Psychopharmacology (Berl) (1992) 0.77
Activities of alkaline phosphatase in first trimester chorion biopsy tissue. Prenat Diagn (1985) 0.77
High-dose omeprazole: use of a multiple-dose study design to assess bioequivalence and accuracy of CYP2C19 phenotyping. Ther Drug Monit (1999) 0.77
Stress reverse the anorexia induced by amphetamine and methylphenidate but not fenfluramine. Brain Res (1978) 0.77
The influence of multiple dosing and age on the pharmacokinetics and pharmacodynamics of glipizide in patients with type II diabetes mellitus. Pharmacotherapy (1997) 0.77
Multiple forms of monoamine oxidase in rabbit platelets. Life Sci (1975) 0.77
Opposite effects of chronic imipramine treatment on brain and urine MHPG levels in the rat. Biol Psychiatry (1985) 0.77
Analysis of messages expressed by Echinostoma paraensei miracidia and sporocysts, obtained by random EST sequencing. J Parasitol (2000) 0.77
Reactions of the isolated plaice stomach to applied drugs. Comp Gen Pharmacol (1972) 0.77